Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07839871 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

StatusNot Yet Recruiting
PhasePhase 3
SponsorPfizer
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Pfizer
436 trials monitored
See 32 trials at risk
The purpose of the study is to evaluate the safety, tolerability, and immunogenicity of RSVpreF in children 5 to \<18 years of age at high risk for RSV disease, including those who are immunocompromised.
Trial Details
NCT Number NCT07839871
Lead Sponsor Pfizer
Conditions
(from sponsor)		 Respiratory Syncytial Virus (RSV)
Enrollment 920 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov